Methods for determining pre-amplification levels of a nucleic acid target sequence from post-amplification levels of product

• US 5,710,029 A
• Filed: 06/07/1995
• Issued: 01/20/1998
• Est. Priority Date: 06/07/1995
• Status: Expired due to Term

• Current Assignee: Gen-Probe Incorporated (Hologic Incorporated)
• Original Assignee: Gen-Probe Incorporated (Hologic Incorporated)
• Inventors: Shannon, Karen W., Harvey, Richard C., Castillo, Maria R., Shen, Nancy Lau Liu, Ryder, Thomas Brendan, Billyard, Elizabeth R., Gonzales, Frank R., McDonough, Sherrol H., Kacian, Daniel Louis
• Primary Examiner(s): Marschel, Ardin H.
• Assistant Examiner(s): Riley, Jezia
• Application Number:
  US08/486,705
• Time in Patent Office: 958 Days
• Field of Search: 435/6, 435/91.1, 435/91.2, 435/91.21, 435/91.3, 536/22.1, 536/23.1, 536/24.3, 536/25.32
• US Class Current: 435/6.18
• CPC Class Codes: C12Q 1/6851 Quantitative amplification
• CPC Class Codes: C12Q 1/6865 Promoter-based amplification, e.g. nucleic acid sequence amplification [NASBA], self-sustained sequence replication [3SR] or transcription-based amplification system [TAS]

Abstract

Methods and kits for relating initial amounts of target nucleic acids present in a sample to target-specific amplification products. It has been discovered that the transcription-mediated amplification system is capable of producing a quantitative relationship between target input and target-specific output. Further, the present invention relates to methods for carefully controlling this relationship resulting in an unexpectedly high degree of reproducability. Also described are useful methods for extending the dynamic range of transcription-based amplification systems.

Claims

1. A method for determining the amount of a target nucleic acid sequence present in a sample, comprising:

a) contacting

I) a sample containing one or more copies of said target sequence, and

ii) known amounts of at least one standard nucleic acid with oligonucleotide primers, reagents, a reverse transcriptase activity and an RNA polymerase activity under conditions sufficient to cause a transcription-mediated amplification of said target sequence, if present, under said conditions,

b) amplifying said standard nucleic acid and said target sequence to produce a standard-specific RNA amplicon and a target-specific RNA amplicon,

c) measuring the amount of each said standard-specific amplicons and specific amplicons and said target-specific amplicons produced, and

d) correlating the amount of standard-specific amplicon reaction products with the known pre-amplification amounts of said standard nucleic acid to produce a standard curve, and

e) determining the pre-amplification amount of the target sequence by comparing the measurement of target-specific amplicons made at step c) with said standard curve,

wherein no RNAse H additional to that provided by said reverse transcriptase is used.

2. The method of claim 1 wherein said amplification is conducted under reaction conditions adjusted to have a reproducable dynamic range of at least 3 orders of magnitude, and said adjustment is made by varying the amount of RNA polymerase used in the amplification reaction.

3. The method of claim 2 wherein said conditions are adjusted to have a reproducable dynamic range of at least 4 orders of magnitude.

4. The method of claim 2 wherein said conditions are adjusted to have a reproducable dynamic range of at least 5 orders of magnitude.

5. The method of claim 2 wherein said conditions are adjusted to have a reproducable dynamic range of at least 6 orders of magnitude.

6. The method of claim 2 wherein said conditions are adjusted to have a reproducable dynamic range of at least 7 orders of magnitude.

7. The method of claim 2 wherein said conditions are adjusted to have a reproducable dynamic range of at least 8 orders of magnitude.

8. The method of claim 2 wherein said conditions are adjusted to have a reproducable dynamic range of at least 9 orders of magnitude.

9. The method of claim 1 wherein, at step b), said target sequence and said standard are amplified in the same reaction mixture.

10. The method of claim 1 wherein, at step b), said target sequence and said standard are amplified in different reaction mixtures.

11. The method of claim 1 wherein said target sequence is ribonucleic acid.

12. The method of claim 1 wherein said target sequence is deoxyribonucleic acid.

13. The method of claim 1 wherein said measuring step is performed by hybridizing said target-specific amplicons and said standard-specific amplicons with at least one labeled oligonucleotide probe and determining the amount of label associated with each said hybrids.

14. The method of claim 13 wherein said measuring step is performed by dividing the reaction mixture into two or more portions and providing the labeled oligonucleotide probe to each such portion at a different label specific activity.

15. The method of claim 13 wherein said target-specific amplicons and said standard-specific amplicons each selectively hybridize to different oligonucleotide probes.

16. The method of claim 13 further comprising making serial dilutions of said probe-hybridized amplicons prior to said measuring step.

17. A method for determining the amount of a target nucleic acid sequence present in a sample, comprising:

incubating a reaction mixture containing a DNA-directed DNA polymerase activity, an RNA-directed DNA polymerase activity, an RNAse H activity, a RNA polymerase activity, at least one promoter-primer and said target sequence under conditions sufficient to cause a transcription-mediated nucleic acid amplification reaction, measuring the amount of a target-specific amplicon produced in said reaction, and relating the amount of said amplicon to the amount of target originally present in the sample, wherein no RNAse H additional to that provided by said reverse transcriptase is used.

18. The method of claim 17 wherein said relating step comprises comparing the amount of said amplicon to a standard curve correlating a known pre-amplification amount of a standard nucleic acid with a post-amplification amount of a corresponding standard-specific amplicon.

19. The method of claim 18 wherein said target sequence and said standard nucleic acid are identical.

20. The method of claim 18 wherein said conditions are made submaximal for achieving a standard amplification reaction rate.

21. The method of claim 20 wherein said submaximal condition is caused by altering the concentration of at least one reaction component relative to the concentration of said component present in a second condition for achieving said standard amplification reaction rate.

22. The method of claim 21 wherein said reaction component is an enzyme having an RNA polymerase activity.

23. The method of claim 22 in which the concentration of said enzyme is between about 0.10 and about 20 units per microliter.

24. The method of claim 22 in which the concentration of said enzyme is between about 0.10 and about 10 units per microliter.

25. The method of claim 22 in which the concentration of said enzyme is between about 0.15 and about 1 unit per microliter.

26. The method of claim 22 in which the concentration of said enzyme is between about 0.20 and about 1 unit per microliter.

27. The method of claim 22 in which the concentration of said enzyme is between about 0.20 and about 0.75 units per microliter.

28. The method of claim 21 wherein said reaction component is a divalent metal cation or a salt thereof.

29. The method of claim 21 wherein said reaction component is selected from the group consisting of deoxyribonucleotide triphosphates and ribonucleotide triphosphates.

30. The method of claim 20 wherein said submaximal condition is caused by the addition of an amount of an inhibitor of said amplification reaction to said reaction mixture, wherein said amount does not cause complete inhibition of said amplification reaction.

32. The method of claim 20 wherein said incubating step occurs at a temperature below about 42°

C.

33. The method of claim 32 wherein said incubating step is conducted at a temperature between about 36°

C. and about 41°

C.

34. The method of claim 33 wherein said incubating step is conducted at about 40°

C.

31. A method for determining the amount of a target nucleic acid sequence present in a sample, comprising:

incubating a reaction mixture containing a DNA-directed DNA polymerase activity, an RNA-directed DNA polymerase activity, an RNAse H activity, a RNA polymerase activity, at least one promoter-primer and said target sequence under conditions sufficient to cause a transcription-mediated nucleic acid amplification reaction, measuring the amount of a target-specific amplicon produced in said reaction, and relating the amount of said amplicon to the amount of target originally present in the sample, wherein;

said relating step comprises comparing the amount of said amplicon to a standard curve correlating a known preamplification amount of a standard nucleic acid with a post-amplification amount of a corresponding standard-specific amplicon;

said conditions are made suboptimal for achieving a standard amplification reaction rate; and

said suboptimal condition is caused by the addition of an amount of a chelating agent to said reaction mixture, wherein said amount does not cause complete inhibition of said amplification reaction.

35. A method for determining the amount of a target nucleic acid sequence present in a sample, comprising:

incubating a reaction mixture containing a DNA-directed DNA polymerase activity, an RNA-directed DNA polymerase activity, an RNAse H activity, a RNA polymerase activity, at least one promoter-primer and said target sequence under conditions sufficient to cause a transcription-mediated nucleic acid amplification reaction, measuring the amount of a target-specific amplicon produced in said reaction, and relating the amount of said amplicon to the amount of target originally present in the sample, wherein;

said relating step comprises comparing the amount of said amplicon to a standard curve correlating a known pre-amplification amount of a standard nucleic acid with a post-amplification amount of a corresponding standard-specific amplicon;

said conditions are made suboptimal for achieving a standard amplification reaction rate, and at least one promoter-primer is modified to have a reduced ability to initiate transcription of said target sequence relative to an unmodified promoter-primer.

36. The method of claim 35 wherein a 5'"'"' promoter sequence of said promoter-primer comprises a portion of SEQ ID NO:

9.

37. The method of claim 35 wherein at least one promoter-primer has a 3'"'"' primer sequence containing at least one mismatch to a primer binding site of the target nucleic acid sequence.

38. The method of claim 35 wherein at least one promoter-primer contains a 3'"'"' modification which prevents or lessens primer extension.

39. The method of claim 38 wherein said 3'"'"' modification is selected from the group consisting of:

a ribonucleotide, a 3'"'"' deoxyribonucleotide residue, 3'"'"', 2'"'"' dideoxyribonucleotide residues, a non nucleotide linkage and an alkanediol modification.

40. A method for determining the amount of a target nucleic acid sequence present in a sample comprising the steps:

a) making serial dilutions of said sample,

b) contacting said serially diluted sample with oligonucleotide primers, reagents, a reverse transcriptase activity and an RNA polymerase activity under conditions sufficient to promote a transcription-mediated amplification reaction,

c) detecting a target-specific RNA amplicon, if present, in reaction mixtures corresponding to said dilutions, and

d) correlating a dilution factor corresponding to the least diluted sample at which no target-specific amplicon was detected with a number of target molecules originally in the undiluted sample as an estimation of said amount,

wherein no RNAse H additional to that provided by said reverse transcriptase is used.